References
- Agrawal N., Mula M.: Treatment of psychoses in patients with epilepsy: an update. Ther. Adv. Psychopharmacol., 2019, 9: 1–10.
- Amir N., Gross-Tsur V.: Paradoxical nomalization in childhood epilepsy. Epilepsia, 1994, 35: 1060–1064.
- Anzellotti F., Franciotti R., Zhuzhuni H., D’Amico A., Thomas A., Onofrj M.: Nonepileptic seizures under levetiracetam therapy: a case report of forced normalization process. Neuropsychiatr. Dis. Treat., 2014, 10: 959–964.
- Bui M., Baslet G., Weisholtz D., McElrath T.: Levetiracetam-induced psychosis in a pregnant woman with prior substance abuse. Harv. Rev. Psychiatry, 2014, 22: 193–200.
- Calle-López Y., Ladino L.D., Benjumea-Cuartas V., Castrillón-Velilla D.M., Téllez-Zenteno J.F., Wolf P.: Forced normalization: A systematic review. Epilepsia, 2019, 60: 1610–1618.
- Fröscher W., Steinert T.: Alternative psychoses of epilepsy. Epileptologia, 2007, 15: 29–40.
- Fröscher W., Steinert T.: Alternativpsychose und forcierte Normalisierung durch Antiepileptika unter besonderer Berücksichtigung der neuen Antiepileptika/Alternative psychoses and forced normalization after seizure control by anticonvulsants with special consideration of the new anticonvulsants (Article in German). Fortschr. Neurol. Psychiatr., 2019,doi: 10.1055/a-0820-3345.
- Kanemoto K., Tadokoro Y., Oshima T.: Psychotic illness in patients with epilepsy. Ther. Adv. Neurol. Disord., 2012, 5: 321–334.
- Kanemoto K., Tsuji T., Kawasaki J.: Reexamination of interictal psychoses based on DSM IV psychosis classification and international epilepsy classification. Epilepsia, 2001, 42: 98–103.
- Kanner A.M.: Psychosis of epilepsy: a neurologist’s perspective. Epilepsy Behav., 2000, 1: 219–227.
- Kanner A.M., Rivas-Grajales A.M.: Psychosis of epilepsy: a multifaceted neuropsychiatric disorder. CNS Spectr., 2016, 21: 247–257.
- Kiteva-Trenchevska G.: Drug induced acute psychosis in epilepsy. Epilepsia. Conference: 13th European Congress on Epileptology. Austria, 2018, 59: 347.
- Klosterkötter J., Penin H.: Epilepsiepsychosen und ihre medikamentöse Behandlung/Epileptic psychoses and their medicamental treatment (Article in German). Fortschr. Neurol. Psychiat., 1989, 57: 61–69.
- Köhler G.K.: Epileptische Psychosen – Klassifikationsversuche und EEG-Verlaufsbeobachtungen/Psychoses in epilepsy – Classification and EEG-studies (Article in German). Fortschr. Neurol. Psychiat., 1975, 43: 101–153.
- Krishnamoorthy E.S., Trimble M.R.: Forced normalization: clinical and therapeutic relevance. Epilepsia, 1999, 40: S57–S64.
- Krishnamoorthy E.S., Trimble M.R., Blumer D.: The classification of neuropsychiatric disorders in epilepsy: a proposal by the ILAE Commission on Psychobiology of Epilepsy. Epilepsy Behav., 2007, 10: 349–353.
- Landolt H.: Some clinical electroencephalographical correlations in epileptic psychoses (twilight states). EEG Clin. Neurophysiol., 1953, 5: 121.
- Landolt H.: Über Verstimmungen, Dämmerzustände und schizophrene Zustandsbilder bei Epilepsie: Ergebnisse klinischer und elektroenzephalographischer. Untersuchungen. Schweiz. Arch. Neurol. Psychiat., 1955, 76: 313–321.
- Majkowski J.: Schizophreniform psychosis with forced EEG normalisation in idiopathic localisation-related epilepsy during levetiracetam (LEV) treatment. Epileptologia, 2005, 13: 57–69.
- Marchetti R.L., Fiore L.A., Peluso M.A., Rigonatti S.P.: Safety and efficacy of ECT in mental disorders associated with epilepsy: report of three cases. J. ECT, 2003, 19: 173–176.
- Mula M.: The Landolt’s phenomenon: an update. Epileptologia, 2010, 18: 39–44.
- Sands T.T., Rahdari S., Oldham M.S., Caminha Nunes E., Tilton N., Cilio M.R.: Long-term safety, tolerability, and efficacy of cannabidiol in children with refractory epilepsy: Results from an expanded access program in the US. CNS Drugs, 2019, 33: 47–60.
- Schmitz B.: Psychiatrische Aspekte bei Epilepsien/Psychiatric aspects of epileptic disorders (Article in German). Nervenarzt, 2012, 83: 205–208.
- Schmitz B., Trimble M.: Psychiatrische Epileptologie. Thieme, Stuttgart 2005.
- Tellenbach H.: Epilepsie als Anfallsleiden und als Psychose. Nervenarzt, 1965, 36: 190–202.
- Wiemer-Kruel A., Ernst J.-P., Fischereder M.: Case report: Effects of treatment with sirolimus for renal reasons on the course of epilepsy in a patient with tuberous sclerosis complex. Epilepsia, 2009, 50 (Suppl. 6): 49–50.
- Willems L.M.: Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany from 2003 to 2013 – A ten-year overview. Epilepsy Behav., 2018, 83: 28–35.
- Wolf P.: Acute behavioral symptomatology of disappearance of epileptiform EEG abnormality. Paradoxical or “forced” normalization. In: SmithD. Treiman D.D. TrimbleM. (eds), Neurobehavioural problems in epilepsy. Raven Press New York, Advances in Neurology, 1991, 55:127–142.
- Wolf P., Inoue Y., Röder-Wanner U.U., Tsai J.J.: Psychiatric complications of absence therapy and their relation to alteration of sleep. Epilepsia, 1984, 25: 56–59.